BioNTech will do without $100M from Hong Kong-based series B investor

An updated IPO prospectus revealed that BioNTech no longer expects a $100 million contribution to its previously announced series B round from an undisclosed Hong Kong-based investor.

The company's initial IPO filing on Sept. 10 had said BioNTech SE was still waiting

Read the full 417 word article

User Sign In